Table 1 Characteristics of the study population

n

100

101

97

107

Age, years

43.3 (SD 8.11)

45.1 (SD 11.0)

45.7 (SD 7.91)

45.0 (SD 10.8)

 Height, m

1.70 (SD 0.06)

1.81 (SD 0.07)*

1.59 (SD 0.06)

1.67 (SD 0.06)*

 Weight, kg

80.0 (SD 17.8)

95.4 (SD 17.6)*

82.6 (SD 19.0)

72.4 (SD 16.9)*

 BMI, kg/m²

27.5 (SD 5.76)

29.0 (SD 5.20)*

32.8 (SD 7.23)

26.0 (SD 5.60)*

 WC, cm

93.5 (SD 15.5)

102 (SD 14.4)*

93.6 (SD 15.6)

84.7 (SD 13.0)*

 SBP, mmHg

137 (SD 16.0)

128 (SD 10.4)*

129 (SD 15.2)

120 (SD 12.4)*

 DBP, mmHg

88 (SD 10.8)

80 (SD 7.44)*

79 (SD 8.66)

74 (SD 7.70)*

 PP, mmHg

50 (SD 8.31)

48 (SD 6.98)

50 (SD 9.76)

46 (SD 7.63)*

 HR, beats/min

79.2 (SD 11.4)

72.0 (SD 11.1)*

80.3 (SD 10.1)

75.0 (SD 8.80)*

 PWV, ms

9.20 (SD 2.35)

8.59 (SD 1.35)*

8.21 (SD 1.38)

7.51 (SD 1.30)*

 TPR, mmHg/ml/s

1.03 (0.63; 1.78)

0.98 (0.65; 1.62)

0.90 (0.56; 1.51)

0.98 (0.60; 1.66)

 CK activity, U/l

127 (42.7; 427)

115 (46.8; 245)

75.9 (26.9; 195)

62.8 (30.2; 123)*

 HbA1c, %

6.24 (SD 1.23)

5.66 (SD 0.48)*

5.91 (SD 1.14)

5.37 (SD 0.29)*

 TC, mmol/l

4.74 (SD 1.17)

5.58 (SD 1.20)*

4.44 (SD 1.20)

5.50 (SD 1.35)*

 HDL-C, mmol/l

1.05 (SD 0.37)

1.00 (SD 0.27)

1.20 (SD 0.31)

1.40 (SD 0.42)*

 TG, mmol/l

1.82 (SD 1.59)

1.51 (SD 0.87)

1.04 (SD 0.64)

0.90 (SD 0.48)

 CRP, mg/l

2.73 (0.28; 15.1)

1.80 (1.00; 7.94)*

7.14 (0.78; 35.5)

2.23 (0.99; 14.5)*

 Cotinine, ng/ml

35 (SD 65.2)

30.9 (SD 96.7)

18.9 (SD 55.7)

15.2 (SD 53.2)

 γ-GT, U/l

62.7 (23.4; 331)

27.3 (11.0; 89.1)*

34.9 (16.6; 100)

13.8 (6.17; 38.9)*

 TEE, kcal/day

2702 (SD 793)

3674 (SD 2059)*

2652 (SD 797)

2567 (SD 612)

 HT, n

79

70

56

31*

 HIV infected, n

13

0*

6

0*

 Statins, n

1

6

1

3

 HT medication, n

20

9*

23

9*